We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
(+58%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Honeywell
HON
|
+$33.2M |
| 4 |
JPMorgan Chase
JPM
|
+$32.4M |
| 5 |
CME Group
CME
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$33.3M |
| 2 |
PayPal
PYPL
|
+$33.1M |
| 3 |
Amazon
AMZN
|
+$32.1M |
| 4 |
PPG Industries
PPG
|
+$27.6M |
| 5 |
Autodesk
ADSK
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 14.63% |
| 3 | Healthcare | 13.67% |
| 4 | Financials | 11.93% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Sutro Biopharma
STRO
$379M
| $233K | ﹤0.01% |
2,998
-939
| -24% | -$90.1K |
|
1752
Beam Therapeutics
BEAM
$2.58B
| $232K | ﹤0.01% |
+8,300
| New | +$179K |
|
|
DOOR
1753
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $231K | ﹤0.01% |
2,975
-9,625
| -76% | -$584K |
|
|
VNTR
1754
DELISTED
Venator Materials PLC
VNTR
| $231K | ﹤0.01% |
129,036
+113,951
| +755% | +$177K |
|
1755
Pixelworks
PXLW
$38.8M
| $230K | ﹤0.01% |
5,925
-263
| -4% | -$11.4K |
|
|
TBRG
1756
DELISTED
TruBridge
TBRG
| $229K | ﹤0.01% |
+10,069
| New | +$225K |
|
1757
CALL
Netflix
NFLX
$292B
| $228K | ﹤0.01% |
+5,000
| New | +$213K |
|
|
1758
PUT
Netflix
NFLX
$292B
| $228K | ﹤0.01% |
+5,000
| New | +$213K |
|
|
ONDK
1759
DELISTED
On Deck Capital, Inc.
ONDK
| $228K | ﹤0.01% |
316,640
+191,390
| +153% | +$188K |
|
1760
IAMGOLD
IAG
$8.47B
| $227K | ﹤0.01% |
+57,366
| New | +$197K |
|
1761
IDEAYA Biosciences
IDYA
$3.41B
| $227K | ﹤0.01% |
16,009
+3,608
| +29% | +$28.4K |
|
1762
Trip.com Group
TCOM
$27.5B
| $227K | ﹤0.01% |
+8,744
| New | +$220K |
|
1763
Upland Software
UPLD
$12M
| $227K | ﹤0.01% |
+654
| New | +$204K |
|
1764
CALL
AbbVie
ABBV
$458B
| $226K | ﹤0.01% |
+2,300
| New | +$203K |
|
|
1765
PUT
AbbVie
ABBV
$458B
| $226K | ﹤0.01% |
+2,300
| New | +$203K |
|
1766
CALL
PepsiCo
PEP
$186B
| $225K | ﹤0.01% |
+1,700
| New | +$224K |
|
|
1767
PUT
PepsiCo
PEP
$186B
| $225K | ﹤0.01% |
+1,700
| New | +$224K |
|
1768
Arcturus Therapeutics
ARCT
$157M
| $224K | ﹤0.01% |
+4,796
| New | +$165K |
|
1769
MGP Ingredients
MGPI
$378M
| $224K | ﹤0.01% |
+6,109
| New | +$218K |
|
1770
CALL
Coca-Cola
KO
$354B
| $223K | ﹤0.01% |
+5,000
| New | +$230K |
|
|
1771
PUT
Coca-Cola
KO
$354B
| $223K | ﹤0.01% |
+5,000
| New | +$230K |
|
1772
KRONOS Worldwide
KRO
$761M
| $223K | ﹤0.01% |
21,433
+1,373
| +7% | +$12.9K |
|
1773
Royal Bank of Canada
RY
$291B
| $223K | ﹤0.01% |
+3,283
| New | +$209K |
|
1774
WesBanco
WSBC
$3.95B
| $223K | ﹤0.01% |
+10,974
| New | +$240K |
|
|
AHT
1775
Ashford Hospitality Trust
AHT
$21M
| $222K | ﹤0.01% |
+307
| New | +$238K |
|
Similar funds
Squarepoint's Q2 2020 Portfolio in Review
As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.
- Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
- Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
- Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
- Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
- Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
- Squarepoint opened 906 new positions and closed 520 in Q2 2020.
- Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.
Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.